中文/English
 Add to Calendar

Novel Drug Delivery System China 2011, will bring together both scientific and business leaders experienced in drug delivery, formulation, R&D, commercialization, business development from 20+ China pharmaceutical companies, 20+ multinational pharmaceutical companies to discuss and showcase latest regulatory, market trend, technology, commercialization based on multiple formats including inspiring keynote speeches, 2 interactive workshop, 2 panel discussions, 2 case studies, 8 interactive Q&A. There’s no better way for you to optimize your time, resources and learning scientific technology and gain business opportunity with 120+ high-level attendees than by attending NDDS China 2011. Check Agenda Details

 

 

 

 
 Keynote Speakers Include:

        Chairman

Li Chen
President, CEO/SAPA China Club President
Hua Medicine Limited
           

Pei Yuanying
Professor
Fudan University

                         
       

Marie-Paule Benassi
1st counselor
EU Delegation in

           

Chen Qinghua
Researcher        
Shanghai Institute of Pharmaceutical Industry

             
         

Richard Korsmeyer
Head, Business Development & Licensing for Pharmaceutical Sciences
Pfizer

           

Marcel de Matas
Principal Scientist-Formulation Science
AstraZeneca

             
          Wei-Guo Dai
Fellow(Corporate Director Level), Drug Delivery & Device Development
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
 
           

Wang Xinglin
Director, Formulation
Tianjin Institute of Pharmaceutical Research

             
          Liang Chaofeng
Deputy Director
Guangzhou Institute of Pharmaceutical Industry
            Jin Fang
Director of Shanghai Engineering Research Center of Respiratory Medicine
Shanghai Institute of Pharmaceutical Industry
             
         

Lucy Xu
Group Head
Novartis

            Xu Yuhong
Professor, Pharmaceutical Department
Shanghai Jiaotong University
                         
         

Zhixuan Wang
Senior Scientist, Chemical & Pharmaceutical Profiling
Novartis

           

Guang Cheng
Director& Deputy General Manager
Jiangsu Engineering Research Center for Liposomal Drug
Nanjing Luye Sike Pharmaceutical Co., Ltd

                         
       
 
Prof. Xian-ming Zeng
Sr. Director, Global Respiratory R&D
TEVA Branded Pharmaceutical Products R&D 
 
         
Ling Chen
VP, R & D Operations
GlaxoSmithKline
                           
       
Ravi Shanker
Senior Research Fellow
Pfizer
         
Jun Han
President
SOTA Pharmaceutical Inc
.
 
                           
          Jason Chen
Executive Director
Simcere Pharmaceutical Group
             
Zhang Jundong
R&D Director, SinePharm
Shanghai Pharma
                         
       
Ping Qineng
Professor
China Pharmaceutical University
         
Weiping Yu
Chief Scientist
Libang Health Group Co. Ltd
                         
       

Song Mingxian
Secretary General
China Pharmaceutical Excipients Committee (CPEC)

             
 

 

Regulation Environment
Registration of new NDDS/formulation products from SFDA, FDA, EU
Registration case study from pharmaceutical company
Market Trend & Commercialization Outlook
NDDS outlook for next 5-10 years in china and globally
NDDS R&D Trend from China’s big pharmas and international big pharmas
NDDS Commercialization
NDDS Updates and Technology/Platform
Oral Drug Delivery System , Inhalation Drug Delivery System , Injection Drug Delivery System, etc
Technologies: sustained / controlled release, bioavailability enhancement, nanoparticles,liposome, targeted DDS, solubility enhancement, etc.

More

download

Registration | FAQs | Download | Contact Us | About Us | Terms & Conditions | Privacy Policy
For more information, please contact: Tel: +86-21-61573919 Fax: +86-21-61577299 Email:conferencechina@ubm.com Add:9F, Ciros Plaza, No.388 West Nanjing Road, Shanghai 200003
Copyright ©UBM 2010-2011, All Rights Reserved.